Libby Kitslaar oversees the corporate practice in Jones Day's Chicago Office, and she has been the principal lawyer in a wide variety of U.S. and international M&A and corporate transactions, including complex acquisitions and divestitures, carve-outs, restructurings, public offerings, and joint ventures. In addition to her transactional work, Libby advises boards of directors, special committees, and investors on a broad range of corporate governance and compliance matters, including federal securities and listing requirements, executive compensation, fiduciary duty, takeover preparedness, and disclosure and trading policy.

Libby's representations include a wide variety of global and complex, cross-border acquisitions, including representing Abbott Laboratories on its $6.9 billion acquisition of BASF's worldwide pharmaceutical business and its $2.8 billion cash tender offer for Advanced Medical Optics; Veolia on its $1.9 billion sale of its U.S. solid waste business; Bridgestone Corporation on its $1.05 billion merger with Bandag; Duchossois Industries on its acquisition of Milestone AV Technologies and its $315 million cash tender offer to acquire AMX Corporation; Galileo International on its $3.2 billion merger with Cendant Corporation; Rykoff-Sexton on its $1.4 billion merger with JP Foodservice; and JohnsonDiversey on its $2.6 billion recapitalization and on its $1.6 billion acquisition of Unilever's worldwide institutional cleaning business.

Libby has been recognized as a leading lawyer by numerous industry publications, including Chambers USA (2007-2014), which describes her as an "outstanding negotiator" providing "practical commercial advice" and "easy to do business with." In 2012, she was on the shortlist of Chambers USA's Women in Law Awards-Corporate/M&A Lawyer of the Year.

Libby is a frequent author and lecturer on M&A, securities law, and corporate governance topics.